Insulin glargine use is not associated with an increased risk of breast cancer compared to NPH insulin and detemir insulin
2020
Abstract
Summary with commentary. Citation: Bradley MC, Chillarige Y, Lee H, et al.
Similar breast cancer risk in women older than 65 years initiating glargine, detemir, and NPH insulins. Diabetes Care 2020; 43: 785-792.